Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LaneLabs is a nutraceutical company specializing in the development and marketing of unique dietary supplements and natural health products. Founded in 1994, the company gained prominence for its shark cartilage product, BeneFin, and its rice bran extract, MGN-3. The company faced significant regulatory scrutiny from the FDA in the early 2000s regarding unsubstantiated health claims for treating cancer and other diseases. Following a court-ordered restructuring, the company shifted its focus toward bone health and topical skin care. In 2014, LaneLabs was acquired by The GHT Companies, which integrated the brand into its broader health and wellness portfolio. Today, the brand is primarily recognized for its AdvaCAL calcium supplements and immune support products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LaneLabs.